During the past decade, SUNY - Upstate Medical University Div. of Hematology-Oncology conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 5 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are "Multiple Myeloma" (2 trials), "Adenocarcinoma" (1 trials), "B-cell Chronic Lymphocytic Leukemia" (1 trials), "Carcinoma" (1 trials) and "Carcinoma, Large Cell" (1 trials). Many other conditions were trialed in "SUNY - Upstate Medical University Div. of Hematology-Oncology" in a lesser frequency.

Most popular intervention types in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Dovitinib" (1 trials), "Lenalidomide" (1 trials), "Placebo" (1 trials) and "Sorafenib" (1 trials). Other intervention names were less common.

The vast majority of trials in "SUNY - Upstate Medical University Div. of Hematology-Oncology" are 7 trials for "All" genders.

Currently, there are NaN active trials in "SUNY - Upstate Medical University Div. of Hematology-Oncology". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in SUNY - Upstate Medical University Div. of Hematology-Oncology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in SUNY - Upstate Medical University Div. of Hematology-Oncology, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".